Quick Answer
INTUITIVE SURGICAL INC reported R&D Expense of $1.31 billion for fiscal year 2025.
INTUITIVE SURGICAL INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.31B | +14.5% |
| 2024 | $1.15B | +14.7% |
| 2023 | $998.80M | +13.6% |
| 2022 | $879.00M | +31.0% |
| 2021 | $671.00M | +12.8% |
| 2020 | $595.10M | +6.8% |
| 2019 | $557.30M | +33.3% |
| 2018 | $418.10M | +27.2% |
| 2017 | $328.60M | +37.1% |
| 2016 | $239.60M | +21.4% |
| 2015 | $197.40M | +10.9% |
| 2014 | $178.00M | +6.1% |
| 2013 | $167.70M | -1.4% |
| 2012 | $170.00M | +21.3% |
| 2011 | $140.20M | +20.9% |
| 2010 | $116.00M | +22.0% |
| 2009 | $95.10M | +19.8% |
| 2008 | $79.40M | +62.5% |
| 2007 | $48.86M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $329.40M | +15.2% | +5.1% |
| June 30, 2025 | $313.30M | +11.9% | -0.9% |
| March 31, 2025 | $316.20M | +11.1% | +10.6% |
| September 30, 2024 | $286.00M | +14.7% | +2.1% |
| June 30, 2024 | $280.10M | +14.6% | -1.5% |
| March 31, 2024 | $284.50M | +16.2% | +14.1% |
| September 30, 2023 | $249.40M | +14.9% | +2.0% |
| June 30, 2023 | $244.40M | +17.9% | -0.2% |
- INTUITIVE SURGICAL INC showed an increase of +14.5% in R&D Expense compared to the prior fiscal year.
- Over the 2007–2025 period, INTUITIVE SURGICAL INC’s r&d expense has grown by 2584.9% (from $48.86 million to $1.31 billion).
- The most recent figure is from INTUITIVE SURGICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: